Literature DB >> 27663392

Community-dwelling older people's attitudes towards deprescribing in Canada.

Caroline Sirois1, Nicole Ouellet2, Emily Reeve3.   

Abstract

BACKGROUND: While there is evidence that supervised withdrawal of inappropriate medications might be beneficial for individuals with polypharmacy, little is known about their attitudes towards deprescribing.
OBJECTIVE: This study aimed to describe the situation among older community-dwelling Canadians.
METHODS: A self-administered survey was adapted from the Patients' Attitudes Towards Deprescribing questionnaire and distributed to 10 community pharmacies and 2 community centers. The participants rated their agreement on statements about polypharmacy/deprescribing on a 5-point, Likert-type scale. Correlations between the desire to have medications deprescribed and survey items were evaluated using Spearman's Rho and Goodman and Kurska's gamma rank correlations.
RESULTS: From the 129 participants, 63% were women [median age: 76 (IQR:71-80); median number medication: 6 (IQR: 3-8)]. A proportion of 50.8% (95%CI: 41.6%-60.0%) expressed the desire to reduce their number of medications. This desire was strongly correlated with the individuals' feeling of taking a large number of medications and moderately correlated with the belief that some of the medications were no longer needed or that they were experiencing side effects.
CONCLUSIONS: The results show that older individuals in the community are eager to undertake deprescribing, especially if they have a large number of medications, are experiencing side effects or feel some medications are no longer necessary.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Attitudes; Deprescribing; Elderly; Perceptions; Polypharmacy

Mesh:

Year:  2016        PMID: 27663392     DOI: 10.1016/j.sapharm.2016.08.006

Source DB:  PubMed          Journal:  Res Social Adm Pharm        ISSN: 1551-7411


  31 in total

1.  Continuation or deprescribing of proton pump inhibitors: A consult patient decision aid.

Authors:  Wade Thompson; Barbara Farrell; Vivian Welch; Peter Tugwell; Cynthia Way; Lisa Richardson; Lise M Bjerre
Journal:  Can Pharm J (Ott)       Date:  2018-12-17

2.  Psychoactive medication use among older community-dwelling Americans.

Authors:  Yara K Haddad; Feijun Luo; Mamta V Karani; Zachary A Marcum; Robin Lee
Journal:  J Am Pharm Assoc (2003)       Date:  2019-06-14

3.  One-year persistence of potentially inappropriate medication use in older adults: A population-based study.

Authors:  Barbara Roux; Caroline Sirois; Marc Simard; Marie-Eve Gagnon; Marie-Laure Laroche
Journal:  Br J Clin Pharmacol       Date:  2020-02-03       Impact factor: 4.335

4.  Nursing Home Residents' Thoughts on Discussing Deprescribing of Preventive Medications.

Authors:  Wade Thompson; Ida Theemann Jacobsen; Dorte Ejg Jarbøl; Peter Haastrup; Jesper Bo Nielsen; Carina Lundby
Journal:  Drugs Aging       Date:  2020-03       Impact factor: 3.923

5.  Assessment of Attitudes Toward Deprescribing in Older Medicare Beneficiaries in the United States.

Authors:  Emily Reeve; Jennifer L Wolff; Maureen Skehan; Elizabeth A Bayliss; Sarah N Hilmer; Cynthia M Boyd
Journal:  JAMA Intern Med       Date:  2018-12-01       Impact factor: 21.873

6.  Willingness to Change Medications Linked to Increased Fall Risk: A Comparison between Age Groups.

Authors:  Yara K Haddad; Mamta V Karani; Gwen Bergen; Zachary A Marcum
Journal:  J Am Geriatr Soc       Date:  2018-12-13       Impact factor: 5.562

7.  Deprescribing in the context of multiple providers: understanding patient preferences.

Authors:  Amy Linsky; Mark Meterko; Barbara G Bokhour; Kelly Stolzmann; Steven R Simon
Journal:  Am J Manag Care       Date:  2019-04       Impact factor: 2.229

8.  Factors associated with patient preferences towards deprescribing: a survey of adult patients on prescribed medications.

Authors:  Takuya Aoki; Yosuke Yamamoto; Tatsuyoshi Ikenoue; Shunichi Fukuhara
Journal:  Int J Clin Pharm       Date:  2019-02-05

9.  Older Patient and Caregiver Perspectives on Medication Value and Deprescribing: A Qualitative Study.

Authors:  Aimee N Pickering; Megan E Hamm; Alicia Dawdani; Joseph T Hanlon; Carolyn T Thorpe; Walid F Gellad; Thomas R Radomski
Journal:  J Am Geriatr Soc       Date:  2020-02-17       Impact factor: 5.562

10.  Poly-de-prescribing to treat polypharmacy: efficacy and safety.

Authors:  Doron Garfinkel
Journal:  Ther Adv Drug Saf       Date:  2017-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.